Tectonic Advisors LLC Sells 184 Shares of Encompass Health Co. (NYSE:EHC)

Tectonic Advisors LLC reduced its stake in shares of Encompass Health Co. (NYSE:EHC) by 2.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,152 shares of the company’s stock after selling 184 shares during the quarter. Tectonic Advisors LLC’s holdings in Encompass Health were worth $568,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in EHC. CIBC Asset Management Inc increased its position in shares of Encompass Health by 3.5% during the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock worth $286,000 after purchasing an additional 100 shares in the last quarter. Miracle Mile Advisors LLC grew its stake in Encompass Health by 3.0% during the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock worth $354,000 after buying an additional 112 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after buying an additional 137 shares in the last quarter. V Square Quantitative Management LLC boosted its holdings in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares in the last quarter. Finally, Verdence Capital Advisors LLC grew its position in Encompass Health by 4.6% during the 3rd quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock worth $355,000 after acquiring an additional 160 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on EHC shares. KeyCorp lifted their price objective on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Barclays raised their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Finally, Royal Bank of Canada upped their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Stock Up 1.0 %

Shares of NYSE:EHC opened at $102.18 on Thursday. The company has a 50 day moving average of $96.43 and a 200-day moving average of $95.08. Encompass Health Co. has a one year low of $71.79 and a one year high of $104.55. The stock has a market cap of $10.29 billion, a price-to-earnings ratio of 24.68, a P/E/G ratio of 1.18 and a beta of 0.90. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.